Displaying 1 - 2 of 2
| Active Ingredient | SODIUM VALPROATE |
| Therapeutic Class | ANTICONVULSANTS MISCELLANEOUS |
| Indications | Grand mal, petit mal, myoclonic and temporal lobe seizures. |
| Caution |
Nausea, vomiting. Ataxia, increase in appetite and weight gain. C.f. Prescribing in liver disease p. 17. |
| Dose Range | Adult: i.v. inj over 3-5 minutes 10mg/kg followed by i.v infusion to a max.2.5g daily. Child 1 mth -12 yrs: Initially orally 5-7.5mg/kg twice daily, usual maintainence dose 12.5-15mg/kg twice daily . Child 12-18 yrs: Initially 300mg twice daily i |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | SODIUM VALPROATE | VALPROIC ACID |
| Therapeutic Class | ANTICONVULSANTS MISCELLANEOUS |
| Indications | All types of epilepsy. Most suitable for patients needing high doses, on poly therapy or on multiple daily doses. |
| Caution | As for sodium valproate. |
| Dose Range |
Adult: Initially 600mg daily in two divided doses, increasing by 200mg daily at 3 day intervals to 1-2g or a maximum of 2.5g/day . Pediatric over 20kg: Initially 400mg/day in divided doses increasing to 20-30mg/kg daily or a maximum of 35mg/kg/day . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |